nodes	percent_of_prediction	percent_of_DWPC	metapath
Iodipamide—Cyanosis—Teniposide—lymphatic system cancer	0.0707	0.0707	CcSEcCtD
Iodipamide—Pallor—Teniposide—lymphatic system cancer	0.0604	0.0604	CcSEcCtD
Iodipamide—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.0242	0.0242	CcSEcCtD
Iodipamide—Renal failure—Fludarabine—lymphatic system cancer	0.0242	0.0242	CcSEcCtD
Iodipamide—Flushing—Teniposide—lymphatic system cancer	0.0233	0.0233	CcSEcCtD
Iodipamide—Swelling—Carmustine—lymphatic system cancer	0.0232	0.0232	CcSEcCtD
Iodipamide—Chills—Teniposide—lymphatic system cancer	0.0225	0.0225	CcSEcCtD
Iodipamide—Swelling—Mitoxantrone—lymphatic system cancer	0.0215	0.0215	CcSEcCtD
Iodipamide—Agitation—Teniposide—lymphatic system cancer	0.0201	0.0201	CcSEcCtD
Iodipamide—Chills—Fludarabine—lymphatic system cancer	0.0198	0.0198	CcSEcCtD
Iodipamide—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.0196	0.0196	CcSEcCtD
Iodipamide—Cyanosis—Methotrexate—lymphatic system cancer	0.0184	0.0184	CcSEcCtD
Iodipamide—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0178	0.0178	CcSEcCtD
Iodipamide—Agitation—Fludarabine—lymphatic system cancer	0.0177	0.0177	CcSEcCtD
Iodipamide—Hypotension—Teniposide—lymphatic system cancer	0.0167	0.0167	CcSEcCtD
Iodipamide—Dyspnoea—Teniposide—lymphatic system cancer	0.0159	0.0159	CcSEcCtD
Iodipamide—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0157	0.0157	CcSEcCtD
Iodipamide—Renal failure—Carmustine—lymphatic system cancer	0.0155	0.0155	CcSEcCtD
Iodipamide—Vomiting—Mechlorethamine—lymphatic system cancer	0.0154	0.0154	CcSEcCtD
Iodipamide—Flushing—Bleomycin—lymphatic system cancer	0.015	0.015	CcSEcCtD
Iodipamide—Chills—Bleomycin—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Iodipamide—Renal failure—Mitoxantrone—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Iodipamide—Nausea—Mechlorethamine—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Iodipamide—Body temperature increased—Teniposide—lymphatic system cancer	0.0141	0.0141	CcSEcCtD
Iodipamide—Dyspnoea—Fludarabine—lymphatic system cancer	0.014	0.014	CcSEcCtD
Iodipamide—Hypersensitivity—Teniposide—lymphatic system cancer	0.0132	0.0132	CcSEcCtD
Iodipamide—Flushing—Carmustine—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Iodipamide—Body temperature increased—Fludarabine—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Iodipamide—Chills—Mitoxantrone—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Iodipamide—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Iodipamide—Tremor—Carmustine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Iodipamide—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Iodipamide—Vomiting—Teniposide—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Iodipamide—Agitation—Carmustine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Iodipamide—Headache—Teniposide—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Iodipamide—Agitation—Vincristine—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Iodipamide—Hypotension—Bleomycin—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Iodipamide—Nausea—Teniposide—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Iodipamide—Dyspnoea—Bleomycin—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Iodipamide—Vomiting—Fludarabine—lymphatic system cancer	0.00997	0.00997	CcSEcCtD
Iodipamide—Headache—Fludarabine—lymphatic system cancer	0.00983	0.00983	CcSEcCtD
Iodipamide—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00978	0.00978	CcSEcCtD
Iodipamide—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00958	0.00958	CcSEcCtD
Iodipamide—Hypotension—Carmustine—lymphatic system cancer	0.00938	0.00938	CcSEcCtD
Iodipamide—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00933	0.00933	CcSEcCtD
Iodipamide—Nausea—Fludarabine—lymphatic system cancer	0.00932	0.00932	CcSEcCtD
Iodipamide—Body temperature increased—Bleomycin—lymphatic system cancer	0.00909	0.00909	CcSEcCtD
Iodipamide—Hypotension—Vincristine—lymphatic system cancer	0.00896	0.00896	CcSEcCtD
Iodipamide—Dyspnoea—Carmustine—lymphatic system cancer	0.00895	0.00895	CcSEcCtD
Iodipamide—Hypotension—Mitoxantrone—lymphatic system cancer	0.00872	0.00872	CcSEcCtD
Iodipamide—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00847	0.00847	CcSEcCtD
Iodipamide—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00832	0.00832	CcSEcCtD
Iodipamide—Body temperature increased—Carmustine—lymphatic system cancer	0.00794	0.00794	CcSEcCtD
Iodipamide—Body temperature increased—Vincristine—lymphatic system cancer	0.00758	0.00758	CcSEcCtD
Iodipamide—Hypersensitivity—Carmustine—lymphatic system cancer	0.0074	0.0074	CcSEcCtD
Iodipamide—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00738	0.00738	CcSEcCtD
Iodipamide—Vomiting—Bleomycin—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Iodipamide—Renal failure—Methotrexate—lymphatic system cancer	0.00717	0.00717	CcSEcCtD
Iodipamide—Hypersensitivity—Vincristine—lymphatic system cancer	0.00706	0.00706	CcSEcCtD
Iodipamide—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00688	0.00688	CcSEcCtD
Iodipamide—Nausea—Bleomycin—lymphatic system cancer	0.00683	0.00683	CcSEcCtD
Iodipamide—Dizziness—Carmustine—lymphatic system cancer	0.00664	0.00664	CcSEcCtD
Iodipamide—Vomiting—Carmustine—lymphatic system cancer	0.00638	0.00638	CcSEcCtD
Iodipamide—Dizziness—Vincristine—lymphatic system cancer	0.00634	0.00634	CcSEcCtD
Iodipamide—Headache—Carmustine—lymphatic system cancer	0.00629	0.00629	CcSEcCtD
Iodipamide—Vomiting—Vincristine—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Iodipamide—Headache—Vincristine—lymphatic system cancer	0.006	0.006	CcSEcCtD
Iodipamide—Nausea—Carmustine—lymphatic system cancer	0.00596	0.00596	CcSEcCtD
Iodipamide—Vomiting—Mitoxantrone—lymphatic system cancer	0.00593	0.00593	CcSEcCtD
Iodipamide—Chills—Methotrexate—lymphatic system cancer	0.00587	0.00587	CcSEcCtD
Iodipamide—Headache—Mitoxantrone—lymphatic system cancer	0.00585	0.00585	CcSEcCtD
Iodipamide—Nausea—Vincristine—lymphatic system cancer	0.00569	0.00569	CcSEcCtD
Iodipamide—Nausea—Mitoxantrone—lymphatic system cancer	0.00554	0.00554	CcSEcCtD
Iodipamide—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Iodipamide—Hypotension—Methotrexate—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Iodipamide—Dyspnoea—Methotrexate—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Iodipamide—Body temperature increased—Methotrexate—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Iodipamide—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Iodipamide—Dizziness—Methotrexate—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Iodipamide—Vomiting—Methotrexate—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Iodipamide—Headache—Methotrexate—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Iodipamide—Nausea—Methotrexate—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
